))
The Importance of Digitalization in Pharmaceutical R&D
Manage episode 449058481 series 3382900
Sisällön tarjoaa ACD/Labs. ACD/Labs tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.
Andrew and Graham also share their thoughts on how digitalization can be used alongside machine learning and artificial intelligence tools to assist with the innovation process through generating and enhancing the synthesis of novel chemical molecules.
Listen here to Part 1: Exploring Digital Transformation in Pharma R&D
31 jaksoa
Jaa
